Selection criteria for initiation and renewal of luteinizing hormone-releasing hormone agonist therapy in patients with prostate cancer: a French prospective observational study

MLA

Alain Ruffion, et al. “Selection Criteria for Initiation and Renewal of Luteinizing Hormone-Releasing Hormone Agonist Therapy in Patients with Prostate Cancer: A French Prospective Observational Study.” Therapeutic Advances in Urology, vol. 6, Dec. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....783d912da28100dad464ecaecafda8cd&authtype=sso&custid=ns315887.

APA

Alain Ruffion, Jean-Luc Moreau, Marc Zerbib, Christophe Hennequin, Igor Latorzeff, Dominique Rossi, Jean-Pierre Mignard, Jean-Louis Davin, Stéphane Culine, & Thierry Lebret. (2014). Selection criteria for initiation and renewal of luteinizing hormone-releasing hormone agonist therapy in patients with prostate cancer: a French prospective observational study. Therapeutic Advances in Urology, 6.

Chicago

Alain Ruffion, Jean-Luc Moreau, Marc Zerbib, Christophe Hennequin, Igor Latorzeff, Dominique Rossi, Jean-Pierre Mignard, Jean-Louis Davin, Stéphane Culine, and Thierry Lebret. 2014. “Selection Criteria for Initiation and Renewal of Luteinizing Hormone-Releasing Hormone Agonist Therapy in Patients with Prostate Cancer: A French Prospective Observational Study.” Therapeutic Advances in Urology 6 (December). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....783d912da28100dad464ecaecafda8cd&authtype=sso&custid=ns315887.